Fairer Vaccine Sharing Saves Lives
2026-09-21
Nearly 3m lives could be saved in a future influenza pandemic if vaccine doses were allocated by population rather than purchasing power, a NUS-Lancet Prime commission report finds. The arithmetic is unforgiving. Broader early access lowers the global death toll, even as wealthier states accept more deaths than they would under a market-led scramble.
The report's premise is less charitable than it sounds: vaccine nationalism is an allocation rule, not an accident. Its counterfactual modelling compares distribution based on purchasing power with population-proportional allocation during a flu outbreak. That distinction matters. The projected gain comes not from creating more supply, but from moving scarce doses toward countries that would otherwise wait while mortality rises. In effect, the queue for protection is rewritten before the virus can write its own ledger.
This is the political sting. Governments able to secure doses earliest would surrender part of their advantage, and the model indicates that their domestic death counts would rise as a result. Yet an influenza virus does not honor procurement contracts. The report turns a familiar moral appeal into a blunt policy trade-off: fewer deaths overall, purchased through a less unequal order of access. The vials would remain the same; only the names beside them would change.
Loading...
